Teeth with irreversible pulpitis. Other and unspecified diseases of pulp and periapical tissues
Conditions
Interventions
Intervention 1: Treatment of pain after root canal therapy of vital teeth with irreversible pulpitis using dexamethasone local injection in a double-blind study. Intervention 2: Treatment of pain afte
Treatment - Drugs
Placebo
Treatment of pain after root canal therapy of vital teeth with irreversible pulpitis using dexamethasone local injection in a double-blind study
Treatment of pain after root canal therapy of vital teeth with irreversible pulpitis using betamethasone L.A local injection in a double-blind study.
Treatment of pain after root canal therapy of vital teeth with irreversible pulpitis using placebo local injection in a double-blind study
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
9 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: All the teeth of maxillary and mandibular jaws diagnosed as irreversible pulpitis; with normal probing depth; tenderness; no history of using drugs such as analgesics (except ibuprofen), analgesic and anti-anxiety in the past two weeks; no medical history; no contraindication for prescribing cortisone; teeth with at least dilated periodontal ligament in periapical radiography; no dental implants in studied dental quadrant; approved vitality with pulp tests and cold spray; teeth with clinically diagnosed as irreversible pulpitis with response to electric pulp tester; longitudinal and magnified response (10 seconds); moderate to severe pain after the removal of the ice test cotton ball. Exclusion criteria: Systemic disease or maxillary sinusitis; unstable heart disease; high blood pressure; sensitivity to anesthetic lidocaine, epinephrine and latex; contraindications ofr lidocaine and epinephrine application; facial or oral paresthesia; use of any painkillers, Sedatives, anti-anxiety and corticosteroids during 2 weeks before treatment (except using 1.6 g of ibuprofen daily in past two days); pregnancy; breastfeeding; unreturnable teeth; teeth with full-coverage of restoration; over filling or over instrumentation during treatment; contraindications of using topical corticosteroids; diabetes; long-term steroid use; false positives vitality test observed after tooth necrosis; need to inject opal interpol for increasing the anesthesia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain relief. Timepoint: 6, 12, 24, 48, 72 hours and 7 days after injection. Method of measurement: Visual Analog Scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHelen Jamlou
Faculty of Dentistry,Tabriz University of Medical Sciences
Outcome results
None listed